Synonyms: 2-(4-chlorophenyl)-1-(4-(7-hydroxy-5-methyl-6,7-dihydro-5H-cyclopenta(d)pyrimidin-4-yl)piperazin-1-yl)-3-(isopropylamino)propan-1-one; GDC-0068; GDC-0068 (RG7440); 524Y3IB4HQ; (S)-2-(4-chlorophenyl)-1-(4-((5R,7R)-7-hydroxy-5-methyl-6,7-dihydro-5H-cyclopenta[d]pyrimidin-4-yl)piperazin-1-yl)-3-(isopropylamino)propan-1-one; CHEMBL2177390; (2S)-2-(4-Chlorophenyl)-1-[4-[(5R,7R)-6,7-dihydro-7-hydroxy-5-methyl-5H-cyclopentapyrimidin-4-yl]-1-piperazinyl]-3-[(1-methylethyl)amino]-1-propanone; RG-7440; C24H32ClN5O2; (2s)-2-(4-Chlorophenyl)-1-{4-[(5r,7r)-7-Hydroxy-5-Methyl-6,7-Dihydro-5h-Cyclopenta[d]pyrimidin-4-Yl]piperazin-1-Yl}-3-(Propan-2-Ylamino)propan-1-One; 1-Propanone, 2-(4-chlorophenyl)-1-(4-((5R,7R)-6,7-dihydro-7-hydroxy-5-methyl-5H-cyclopentapyrimidin-4-yl)-1-piperazinyl)-3-((1-methylethyl)amino)-, (2S)-; Ipatasertib [USAN:INN]; GDC0068; 1-Propanone, 2-(4-chlorophenyl)-1-[4-[(5R,7R)-6,7-dihydro-7-hydroxy-5-methyl-5H-cyclopentapyrimidin-4-yl]-1-piperazinyl]-3-[(1-methylethyl)amino]-, (2S)-; AK174371; RG 7440; Ipatasertib (USAN/INN); Ipatasertib; GDC-0068; SCHEMBL191659; GTPL7887; CHEBI:95089; GRZXWCHAXNAUHY-NSISKUIASA-N; AOB87386; Ipatasertib; EX-A2077; BDBM50398379; MFCD22124514; s2808; ZINC68250459; AKOS025396463; BCP9000712; CS-0975; DB11743; SB16560; GDC-0068; NCGC00346714-01; (2S)-2-(4-Chlorophenyl)-1-(4-((5R,7R)-7-hydroxy-5-methyl-6,7-dihydro-5H-cyclopenta(d)pyrimidin-4-yl)piperazin-1-yl(-3-((propan-2-yl)amino)propan-1-one; AC-28420; AS-17027; BC295592; HY-15186; QC-10488; BCP0726000195; AB0033076; FT-0773211; 1001264-89-6; X6541; J3.478.537F; D10641; W-5890; (2S)-2-(4-chlorophenyl)-1-[4-[(5R,7R)-7-hydroxy-5-methyl-6,7-dihydro-5H-cyclopenta[e]pyrimidin-4-yl]piperazin-1-yl]-3-(propan-2-ylamino)propan-1-one; 0RF; AKT inhibitors; Ipatasertib [INN]; D0I4TH; cc-616; Ipatasertib (GDC-0068); A3006; A11246; 1417449-25-2; GDC 0068; UNII-524Y3IB4HQ; RG7440;